Compound class

Cosmetic and copper peptides

Copper peptides, cosmetic ingredients and melanocortin peptides.

Each figure is as the compound's own sources give it, numbered under References. Where they give none, the list says not stated. The half-life the app draws levels with can differ. Reviewed 17 November 2026.

GHK-Cu is the copper form of GHK, a small tripeptide present in human plasma,1 and argireline is a six-amino-acid peptide identified through a rational design programme.2 A 2026 review says formal absorption, distribution, metabolism and excretion studies of the intact GHK-Cu complex have not been reported.3 The class also holds melanocortin peptides. The TGA says no melanotan II product is approved for supply in Australia, and its testing of seized nasal sprays found inconsistent amounts of melanotan II between bottles, which it says increases the chance of adverse events.4 FDA approved bremelanotide (PT-141) as Vyleesi in 2019,5 for premenopausal women with acquired, generalized hypoactive sexual desire disorder.6

Copper and healing peptides 4

Tanning and cosmetic 10

Guides 6

Calculators 5

Compare 2

Logged in Milligram

Share of people who logged a dose in Milligram in the 90 days to 15 November 2026 who logged each compound.

  • GHK-Cu15%
  • Melanotan II3%

GHK-Cu, how often

  • Daily68%
  • Every other day23%
  • Twice a week6%
  • Weekly3%
  • Less often0%

Melanotan II, how often

  • Daily45%
  • Every other day16%
  • Twice a week27%
  • Weekly11%
  • Less often2%

How often: among people with three or more logged doses, by the average gap between their doses.

Aggregated and anonymous, shares of people only. Each compound not listed: too few people logged it to show a share. It describes what people set up in the app, not advice on what to take.

References 11

  1. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. 2018. PMC6073405
  2. Blanes-Mira C, et al. A synthetic hexapeptide (Argireline) with antiwrinkle activity. 2002. PMID 18498523
  3. Mateescu DM, Gavrilescu DM, Mincioaga RI, et al. GHK-Cu as a Bioactive Metallopeptide and Drug-Delivery Cargo: Coordination Chemistry, Formulation Science, Therapeutic Evidence, and a Translational Roadmap. 2026. PMC13610439
  4. Therapeutic Goods Administration (Australia). Melanotan II tanning peptide products found to be inconsistently dosed (safety advisory, 17 August 2026). 2026. tga.gov.au
  5. US Food and Drug Administration, Center for Drug Evaluation and Research. Multi-discipline review, NDA 210557, Vyleesi (bremelanotide). 2019. accessdata.fda.gov
  6. Vyleesi (bremelanotide injection), for subcutaneous use. US prescribing information, DailyMed. DailyMed label
  7. Badenhorst T, Svirskis D, Merrilees M, Bolke L, Wu Z. Effects of GHK-Cu on MMP and TIMP Expression, Collagen and Elastin Production, and Facial Wrinkle Parameters. J Aging Sci 2016. Full text (PDF)
  8. Wang Y, et al. The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study. Am J Clin Dermatol 2013. PMID 23417317
  9. Lintner K, Gerstein F, Solish N. A serum containing vitamins C & E and a matrix-repair tripeptide reduces facial signs of aging as evidenced by Primos analysis and frequently repeated auto-perception. J Cosmet Dermatol 2020;19:3262-3269. PMID 33103342
  10. SCENESSE (afamelanotide) implant, for subcutaneous use. US prescribing information. Clinuvel Inc. DailyMed, record published 13 May 2026. DailyMed label
  11. DSM Nutritional Products. SYN-Peptides: SYN-AKE. Product brochure, 2020. DSM brochure

Each figure is as the compound's own sources give it, numbered under References. Where they give none, the list says not stated. The half-life the app draws levels with can differ. Reviewed 17 November 2026.